T220L
Reported in fluconazole-resistant isolates; typically modest–moderate increases (e.g., ~4–16-fold) depending on background and co-occurring mechanisms.
Moderate increases for voriconazole in some isolates (2–8-fold).
T220L reported in multiple clinical collections; often found in isolates where ERG11 substitutions explain a portion of resistance but efflux/regulatory changes also contribute.
Comments
Post a Comment